Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

Hepatology

Volumn 25, Issue 5, 1997, Pages 1108-1114

  Tatsumi, Tomohide ^a   Takehara, Tetsuo ^a   Katayama, Kazuhiro ^a   Mochizuki, Kiyoshi ^a   Yamamoto, Masato ^a   Kanto, Tatsuya ^a   Sasaki, Yutaka ^a   Kasahara, Akinori ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030904284     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250511     Document Type: Article

References (16)

1. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-1079.
2. Liu Y, Linsley PS. Costimulation of T cell growth. Curr Opin Immunol 1992;4:265-270.
3. Allison JP. CD28-B7 interaction in T cell activation. Curr Opin Immunol 1994;6:414-419.
4. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
5. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 Costimulation. Proc Natl Acad Sci U S A 1993;90:6586-6590.
6. Harding FA, Mcarthur JG, Gross JA, Raulet DH, Allison JP. CD28 mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-609.
7. Linsley PS, Clark EA, Ledbetter JA. T-cell activation antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB1. Proc Natl Acad Sci U S A 1990;87:5031-5035.
8. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J Exp Med 1991;173: 721-730.
9. Linsley PS, Brady W, Urnes M, Grosmaire L, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-569.
10. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989;143:2714-2722.
11. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
12. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366:76-79.
13. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Lombard LA, Gray GS, et al. Cloning of B7-2: a CTLA-4 counter-receptor that Costimulates human T cell proliferation. Science 1993;262:909-911.
14. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, Kim J, et al. Murine B7-2, an alternative CTLA-4 counter-receptor that Costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993;178:2185-2192.
15. Chen C, Gault A, Shen LJ, Nabavi N. Molecular cloning and expression of T cell costimulatory molecule ETC-1 and its characterization as B7-2. J Immunol 1994;152:4929-4936.
16. Yokochi T, Holley RD, Clark EA. B lymphocyte antigen (BB1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 1982;128:823-827.